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There is growing evidence to suggest that chagasic myocardia are exposed to sustained oxidative stress induced injuries that may
contribute to disease progression. Trypanosoma cruzi invasion- and replication-mediated cellular injuries and immune-mediated
cytotoxic reactions are the common source of reactive oxygen species (ROS) during acute infection. Mitochondria are proposed to
bethemajorsourceofROSinchronicchagasichearts.However,ithasnotbeenestablishedyet,whethermitochondrialdysfunction
is a causative factor in chagasic cardiomyopathy or a consequence of other pathological events. A better understanding of oxidative
stress in relation to cardiac tissue damage would be useful in the evaluation of its true role in the pathogenesis of Chagas disease
and other heart diseases. In this review, we discuss the evidence for increased oxidative stress in chagasic disease, with emphasis on
mitochondrial abnormalities, and its role in sustaining oxidative stress in myocardium.
Copyright © 2009 Shivali Gupta et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.ChagasDisease
Chagas disease continues to pose a serious threat to health in
LatinAmericaandM exico ,andisthemostimportantemerg-
ing parasitic disease in developed countries. According to the
World Health Organization, the overall prevalence of human
Trypanosoma cruzi infection is at ∼16–18 million cases,
and ∼120 million people are at risk of infection in Latin
America [1]. In most patients, the early period of T. cruzi
infection goes virtually unnoticed whereas others develop
an acute phase that lasts several weeks and is accompanied
by such nonspeciﬁc symptoms, fever, tachycardia, weakness,
and lymphadenopathy [2, 3]. After acute control of T.
cruzi, infected patients enter an indeterminate phase, deﬁned
by the absence of clinical symptoms although subclinical
pathology may be present. Unfortunately, 15–30 years
after the initial infection, 30–40% of the infected patients
develop life threatening dilated cardiomyopathy associated
with clinical symptoms of ventricular dilation, arrhythmia,
and cardiac arrest [4]. The pathological developments and
clinicalsymptomsvarywidelyamongchagasicpatients[2,5–
7]. Not every individual infected with T. cruzi experiences
theabnormalitiescharacteristicofthethreephasesofChagas
disease: acute, indeterminate, and chronic. These facts make
Chagasdiseaseacomplexdiseaseanddiﬃculttounderstand.
Over the years, a number of mechanisms have been
proposed to explain the pathogenesis of Chagas disease
(reviewed in [8, 9]). There is growing evidence to suggest
that chagasic myocardia are exposed to sustained oxida-
tive stress-induced injuries that may contribute to disease
progression. In this review, we discuss the evidence for
increased oxidative stress in chagasic disease, with emphasis
onmitochondrialabnormalities,aswellaselectrontransport
chain dysfunction, and its role in sustaining oxidative stress
in myocardium.
2.Sourcesof Oxidants
2.1. Overview. Broadly deﬁned, reactive oxygen species
(ROS, e.g., O
•−
2 , •OH, and H2O2)a r ed e r i v a t i v e so fm o l e c -
ular oxygen. ROS are unstable and react rapidly with other
free radicals and macromolecules in chain reactions to
generate increasingly harmful oxidants. ROS are produced2 Interdisciplinary Perspectives on Infectious Diseases
through the action of speciﬁc oxidases and oxygenases (e.g.,
xanthine oxidase, and NADPH oxidase), peroxidases (e.g.,
myeloperoxidase), the Fenton reaction, and are also by-
products of the electron transport chain of mitochondria
[10]. Nitric oxide (•NO) is produced by the enzymatic
activity of nitric oxide synthases (NOS), which oxidize
L-arginine, transferring electrons from NADPH. Diﬀerent
NOS isoforms have been identiﬁed, for example, inducible
NOS (iNOS) in phagocytic cells, mtNOS in mitochondria,
(eNOS) in endothelial cells, and neuronal nNOS [11].
2.2. ROS in Chagasic Hosts. During the course of T. cruzi
infection and disease development, ROS can be produced
as a consequence of tissue destruction caused by toxic
secretionsofparasite,immune-mediatedcytotoxicreactions,
and secondary damage to mitochondria.
In experimental studies, T. cruzi infection has been
suggested to initiate ROS formation via the stimulation
of inﬂammatory mediators, for example, cytokines and
chemokines, which lead to an oxidative burst of phagocytic
cells. Several investigators have used in vitro assay systems
or animal models and demonstrated that T. cruzi-mediated
macrophage activation results in increased levels of O
•−
2 for-
mation, likely by the NADPH oxidase-dependent oxidative
burst [12–14]. In addition to ROS, activated macrophages
can produce large amounts of •NO by iNOS. Accordingly,
TNF-α-a n dI F N - γ-dependent increased iNOS expression
and •NO production is noted in splenocytes of T. cruzi-
infected mice [15] and in macrophages infected in vitro
with T. cruzi [16]. We have found increased levels of
myeloperoxidaseandnitriteintheplasmaofT.cruzi-infected
mice [17] that are markers of neutrophil and macrophage
activation, respectively. Relatively few studies have been
performed to elucidate inﬂammatory oxidative stress in
human patients. In humans, the severity of cardiac disease
was correlated with high plasma levels of TNF-α and •NO
[18]. The •NO level was also increased in indeterminate
individuals in comparison to healthy controls [19]. These
reactive oxidants are important for the control of T. cruzi,
and may elicit toxicity to host cellular components.
Recent studies provide evidence for enhanced mito-
chondrial ROS generation (H2O2 and O
•−
2 ) in chagasic
myocardium. Mitochondria are the prime source of energy
and many of the body’s functions, including those of cardiac
metabolic and contractile activities, require mitochondrial
generation of ATP. Electron microscopic analysis of heart
biopsies from chagasic patients and experimental animals
have shown that with disease development, mitochondrial
degenerative changes, that is, swelling, irregular membranes,
and loss of cristae, accrue in the heart with disease
development [20–23]. Global microarray proﬁling of gene
expression has identiﬁed alterations in several of the mito-
chondrial function related transcripts in the myocardium of
infected humans [24] and experimental animals [25, 26].
The biochemical evidence for the mitochondrial dysfunction
was provided by documentation of a decline in the activities
of respiratory complexes, NADH-ubiquinone reductase (CI)
and ubiquinol-cytochrome c reductase (CIII) [27]a n dA T P
synthase (CV) complex [28] in chagasic murine hearts.
The functional eﬀect of these perturbations was shown by
decreased mitochondrial respiration [29], and reduction in
myocardial and mitochondrial ATP levels [30] in chagasic
experimental models.
Imperatively,mitochondrialdysfunctionalsocontributes
to increased oxidative stress. A low, but constant, production
of superoxide O
•−
2 occurs in mitochondria. The rate of elec-
tron leakage and O
•−
2 formation in mitochondria is closely
related to the coupling eﬃciency between the respiratory
chain and oxidative phosphorylation [31]. The CI and CIII
complexes are the main sites for electron leakage to O2
and O
•−
2 generation in mitochondria [32, 33]. We have
shown a decline in complex I and complex III activities in
the myocardium was associated with excessive leakage of
electronstomolecularoxygenandsustainedROSproduction
in chagasic mice [27]. Further studies identiﬁed that CI
was not the main source of increased ROS in chagasic
hearts. Instead, defects of the myxothiazol-binding site in
CIII complex resulted in enhanced electron leakage towards
the Qo-center, and contributed to increased ROS generation
in chagasic cardiac mitochondria [34]. Thus, conditions
conducive to oxidative stress are presented in the Chagasic
heart.
3.Antioxidants
3.1. Overview. The overall level of cellular ROS and its
biological eﬀects are determined by the relative rates of ROS
generation and the rate of reduction by antioxidants. The
principal enzymatic antioxidants are superoxide dismutase
(SOD), catalase (CAT), peroxiredoxin (Prx), and glutathione
peroxidase (GPx). These enzymes work in tandem to scav-
enge ROS. SOD exists in diﬀerent isoforms, for example,
manganese SOD (MnSOD) in the mitochondrial matrix
and Cu- or Zn-SOD in the cytoplasm, mitochondria inter-
membrane space, and endothelial cell surface [35]. SOD
converts O
•−
2 to H2O2 [36]. CAT, located in peroxisomes,
converts H2O2 to H2Oa n dO 2 [37]. Prx reduces peroxides,
including H2O2 and alkyl hydroperoxides [38]. The ﬁve
isoforms of GPx utilize glutathione (GSH), and reduce
H2O2 or lipid peroxides (ROOH) to H2O or alcohols
(ROH), respectively. The byproduct of this reaction, GSSG is
recycled by glutathione S reductase [38]. The nonenzymatic
antioxidants, for example, vitamin E (α-tocopherol) and
vitamin C (ascorbate), are abundant in aerobic organisms.
V i t a m i nE ,a c t i v ei nm e m b r a n e s ,f u n c t i o n st or e d u c ep e r o x y
radicals. Vitamin C, a highly soluble antioxidant in plasma,
functions by reducing α-tocopherol-lipid peroxide radicals,
particularlyformedinreactionwiththelow-densitylipopro-
teins (LDL) [37].
3.2. Antioxidant Status in Chagasic Host. The myocardium
contains high concentrations of various nonenzymatic
antioxidants such as reduced glutathione (GSH) and vita-
mins A, C, and E, and enzymatic scavengers of ROS,
including GPx and Mn- and CuZn-SOD. GSH, GPx, and
MnSOD are shown to be most critical in cardiac antioxidantInterdisciplinary Perspectives on Infectious Diseases 3
defenses, particularly in protecting the cardiomyocytes from
oxidative injury [39, 40]. We and others have evaluated
the antioxidant/oxidant balance in experimental models of
chagasic disease and human patients. Our experimental
studies showed that the host responds to acute T. cruzi
infection by upregulating glutathione antioxidant defense
constituted by GPx, GSR, and GSH. However, after the
initial burst, the glutathione defense was unresponsive to
chronic oxidative stress, and the cardiac levels of GSH and
MnSOD were signiﬁcantly diminished in chagasic mice [41].
A decline in plasma levels of GSH, the GSH/GSSG ratio
[42,43],andGPxactivity[18],alongwithdecreasedMnSOD
activity in PBMCs of seropositive chagasic patients [42, 43]
is also noted. Decreased antioxidant levels (GPx and SOD)
were correlated with an increase in TNF-α and •NO levels
in human patients [18]. All of these observations suggest an
antioxidant response is not suﬃciently activated to scavenge
the ROS during progressive chagasic disease.
4. Cytotoxicity of Oxidative Stress
4.1. Overview. ROS and •NO, when produced in physiolog-
ical quantities, play critical roles in normal developmental
processes, and control signal transduction mechanisms that
regulate cell proliferation, diﬀerentiation, and death [44, 45].
However, when ROS are produced in excess or for sustained
periods, they may exert toxic eﬀects that damage cells and
tissues, thereby resulting in dysfunction of physiological
processes.ROScanrapidlyoxidizeproteins,lipids,andDNA.
Lipid peroxidation causes damage to membrane integrity
and loss of membrane protein function. Speciﬁcally, 4-
hydroxynonenal (HNE) and malonyldialdehyde (MDA) are
products of the peroxidation of membrane phospholipids
[46–48]. These oxidized lipids are also toxic because they are
highly reactive species that result in oxidative modiﬁcation
of proteins [37]. For example, HNE reacts with Cys, His, or
Lys residues via a Michael addition that results in irreversible
alkylation and introduction of carbonyl groups into proteins
[49]. The direct oxidative attack by ROS on Arg, Lys, Pro,
and Thr residues can also derivatize the proteins and lead to
the formation of protein carbonyls [50, 51]. •NO reacts with
O
•−
2 , to form peroxynitrite (ONOO–). Myeloperoxidase-
dependent oxidation of nitrite (NO
−
2 ) results in formation
of nitrogen dioxide (NO2) and nitryl chloride (NO2Cl).
These reactive nitrogen species (RNS) result in protein
tyrosine nitration that is widely recognized as a hallmark
of nitrosative stress and inﬂammation [52]. Because of
oxidation or nitration, a functional impairment of pro-
teins occurs, and furthermore leads to protein turnover,
for example, degradation by proteases via the proteosome
[53]. DNA can be oxidized by a variety of mechanisms,
resulting in nucleotide damage, for example, formation of
8-oxoguanine lesions. As a result, DNA replication may be
inaccurate leading to mutations and transcription errors.
While mechanisms exist to repair these DNA lesions, the
level of DNA damage may exceed the capacity of the
cellularrepairmechanisms.Furthermore,mtDNAisbelieved
to be particularly susceptible to sustained damage, since
mitochondria may lack appropriate DNA repair mechanisms
[54].
4.2. Oxidative Damage in Chagas Disease. Oxidative stress-
induced injuries are a common ﬁnding in chagasic
myocardium. T. cruzi has the potential to infect a wide
range of host tissues [55]. As discussed above, the inﬂam-
matory inﬁltrate in acutely infected host is mainly con-
stituted of phagocytic cells (e.g., macrophages) and neu-
trophilsthatproduceROS/RNSthroughoxidativeburst[56],
iNOS-dependent •NO release [15], and myeloperoxidase-
dependent HOCl production [57]. Oxidative damage is
a consequence of the extent of oxidative stress and the
antioxidant capacity. A T. cruzi-infected host does respond
to inﬂammatory oxidative stress by an upregulation of
antioxidant response constituted of GPx, GSH, and GST
[41]. Yet, oxidative cellular damage, evidenced by increased
proteincarbonyls,MDA,andGSSGlevels,iswidespread,and
associated with the presence of parasite foci and inﬂamma-
toryinﬁltrateintheheart,aswellasinothermuscletissuesin
acutely infected mice [58]. The acute oxidative damage, thus,
appears to be a bystander eﬀect of inﬂammatory responses
elicited by T. cruzi, and occurs in all muscle tissues.
The immune control of acute parasitemia fails to provide
sterile immunity. The evolution of a chronic phase is
associated with mild-to-moderate diﬀused inﬂammation in
diﬀerent tissues and organs. It would be an oversimpliﬁca-
tion to suggest that cardiac pathology is merely an outcome
of infection and inﬂammation, or parasite persistence that
is suﬃcient to drive an ongoing host immune response
targeted against T. cruzi. An unvarying high degree of
oxidative damage persists mainly in the myocardium of
chronically infected mice, as evidenced by high levels of
MDA, protein carbonyl, and GSSG contents in the heart
compared to ﬁndings in the skeletal muscle and colon
tissue [58]. We propose the persistent activation of oxidative
injurious processes plays an important role in heart-speciﬁc
tissue damage in Chagas disease.
Several observations led us to consider that ROS in
chronic chagasic heart are primarily produced by dys-
functional mitochondria. It is well known that ROS are
generated at several subcellular sites [59] and particularly in
mitochondria [60]. In eﬀect, ∼2% of the O2 consumed by
mitochondria is converted to O
•−
2 due to spontaneous elec-
tron leaks from the respiratory chain [61]. Activated skeletal
and intestinal muscles intermittently require mitochondria
as an energy source, while cardiomyocytes are constantly
dependent upon mitochondrial functions for their energy
requirement for maintaining the contractile and other
metabolic activities. According to energy demand, a ∼30%
cell volume of cardiomyocytes is provided by mitochondria,
while in other tissues mitochondria constitute only 3–6% of
cell volume [62]. Thus, maximal O2 consumption, as would
be expected based upon the number of mitochondria in the
heart, would produce substantial O
•−
2 in the heart through
electron leakage from the respiratory chain. Thus, it can
be inferred that even in normal conditions, heart tissue is
maximally exposed to ROS of mitochondrial origin. Besides4 Interdisciplinary Perspectives on Infectious Diseases
this, ineﬃcient functioning of the respiratory complexes,
as documented in chagasic hearts [27], would result in an
inadequate coupling of the respiratory chain with oxidative
phosphorylation and an excessive release of electrons to
molecular oxygen, leading to an increased mitochondrial
ROS production. We have recently found that the rate of
mitochondrial O
•−
2 generation was substantially increased in
cardiac tissue of infected mice [34], and associated with the
oxidation of several subunits of the respiratory complexes
[41]. The active-site thiol and heme proteins within respira-
tory complexes are particularly vulnerable to ROS [63]. The
oxidative modiﬁcation/degradation of heme proteins of the
complexes release iron, the catalyst of the Fenton reaction,
resulting in the formation/release of •OH radicals [64–66].
Takentogether,theseobservationssuggestthat,underdisease
conditions, mitochondria are vulnerable to oxidative stress,
as well as to becoming the site of an increasing order of ROS
production. We, thus, propose that the acute inﬂammatory
oxidative stress-induced mitochondrial injuries initiate a
feedback cycle of ROS production and oxidative overload
that causes sustained oxidative damage in the myocardium.
A compromise in mitochondrial antioxidant enzyme activity
(MnSOD)in chagasic myocardium would furtherexacerbate
the mitochondrial ROS toxicity. The foregoing studies have
pointed to the pathologic signiﬁcance of oxidative responses
in Chagasic cardiomyopathy.
It is important to note that a high degree of oxidative
stress is detected in the peripheral blood of chagasic mice
[58]. The demonstration of a strong positive correlation
in the heart-versus-blood levels of oxidative stress markers
(MDA and GSSG), and antioxidants (SOD, MnSOD, and
catalase), and the mitochondrial inhibition of respiratory
complexesinchronicallyinfectedmicehavemadeitapparent
that peripheral blood will be useful for understanding the
role of mitochondrial decay and oxidative stress in the
initiation and progression of human chagasic disease.
Subsequently, observations of increased plasma levels of
GSSG and MDA and a decline in GPx activity in seropositive
humans [18, 42] have led to the suggestion that chaga-
sic patients are indeed exposed to an antioxidant/oxidant
imbalance. As in experimental studies, multiple mechanisms
are likely to contribute to increased oxidative stress-induced
damage in chagasic patients. Plasma levels of inﬂammatory
cytokines, •NO [18] and myeloperoxidase activity [17]a r e
increased in seropositive subjects which seems to imply that
the cytotoxic eﬀects of free radicals released by immune cells
would contribute to oxidative pathology in chagasic patients.
The increase in plasma MDA levels in chagasic patients
may also be due to oxidatively modiﬁed lipids released
as a consequence of cellular injuries, most likely, that are
incurredinthecardiactissue.Thisnotionissupportedbythe
observation of intense myocardial oxidative modiﬁcations
[41] associated with the detection of oxidatively modiﬁed
lipids and proteins in the serum [58] of mice infected by
T. cruzi. Additionally, SOD and glutathione (GPx-GSH-GR)
antioxidant defenses, utilized by mammalian cells to cope
with free radicals [67], are found to be compromised in
chagasic patients [18, 42]. These observations support the
idea that glutathione antioxidant defenses, despite being
active,mayonlybepartiallyeﬀectiveinbalancingtheoxidant
level in chagasic patients.
5. AntioxidantAdjunct Therapy
Interventions that reduce the generation or the eﬀects of
ROS may exert beneﬁcial eﬀects in preventing or arresting
oxidative damage. Several therapeutic interventions, for
example, a vitamin E-like antioxidant, an SOD mimetic
[68, 69], and an ONOO– decomposition catalyst [70]h a v e
been examined for their beneﬁcial eﬀects against ROS
in diﬀerent systems. Phenyl-N-tert-butylnitrone (PBN), a
nitrone-based compound, is a potent antioxidant. PBN has
been shown to trap or scavenge a wide variety of free radical
species, including biologically relevant O
•−
2 and hydroxyl
•OH radicals; to increase endogenous antioxidant levels; and
to inhibit free radical generation [71]. In addition, PBN
has been shown to inhibit the expression of a variety of
inﬂammation-associated gene products [72].
In a recent study, we have shown that PBN treatment
of infected mice prevented an oxidative stress-mediated
loss in mitochondrial membrane integrity; preserved redox
potential coupled with mitochondrial gene expression,
and improved respiratory complex activities in infected
myocardium [30]. Importantly, the PBN-mediated normal-
ization of respiratory complex activities led to the inhibition
of a feedback cycle of electron transport chain ineﬃciency,
increased ROS production, and energy homeostasis in acute
chagasic hearts [30]. Others have shown a decline in
oxidative stress in human chagasic patients given Vitamin A
[73]. We propose that antioxidants capable of modulating
or delaying the onset of oxidative insult and mitochondrial
deﬁciencies in the myocardium would prove to be useful in
preserving cardiac functions in Chagas disease.
6. Ischemic InjuryandROS
Approximately 10% of chronic chagasic patients exhibit
signs of ischemic disease [74, 75]. The abnormalities during
isovolemic contraction and the early relaxation phase, in
general ascribed to asynchronous onset of contraction, are
noted in chagasic patients, and are similar to that seen in
patients with conventional ischemic heart disease of other
etiologies [76]. Others have suggested the alterations in
the coronary microcirculation contribute to ischemic tissue
damage in chronic chagasic patients [75, 77–80]. Myocardial
hypoperfusion owing to an aﬀected microvasculature has
also been noted in chagasic heart regions with normal or
mildly impaired wall motion [75, 80].
Hypoxia is a critical outcome of ischemia. In hypoxic
tissues, low availability of oxygen results in electron accu-
mulation in highly reduced respiratory complexes that lead
to severely compromised respiration and ATP synthesis [81–
83]. Ischemia also inﬂuences mitochondrial function via
change in calcium ﬂux [84], cyt c depletion (reviewed
in [85]), and decline in intrinsic level of MnSOD—the
mtROS scavenger [86]. The ineﬃcient scavenging of mtROS
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of ROS at reperfusion [87]. Mitochondrial loss of cyt c
is considered to potentate ROS production at reperfusion
because (a) cyt c is a catalytic scavenger for mitochondrial
O
•−
2 , and (b) loss of cyt c results in highly reduced state of
respiratory complexes I, II, and III, thus, favoring electron
release to molecular oxygen and O
•−
2 production [88, 89].
These observations suggest that mitochondrial inhibition
of respiration and ATP synthesis resulting from hypoxia,
coupledwithanincreaseinO
•−
2 formationandROS-induced
injuriouseﬀectsduringreperfusion,potentiallycontributeto
the contractile dysfunction and cell death in Chagasic hearts,
to be conﬁrmed in future studies.
7. Summary
Sustained ROS generation of inﬂammatory and mito-
chondrial origin, coupled with an inadequate antioxidant
response, result in the ineﬃcient scavenging of ROS in
the heart, and lead to long-term oxidative stress, and
subsequently, to oxidative damage of the cardiac cellular
components during chagasic disease. The alterations in
biomarkers of oxidant and antioxidant status and in res-
piratory complex activities in the heart and blood/plasma
of infected host appear to have same pathologic tendencies,
which led to the suggestion that peripheral blood would be
a useful tissue for investigating the pathologic importance
ofimpairedmitochondrialfunctionandoxidant/antioxidant
status in chagasic disease development. Further studies
should examine the pathological relevance of oxidative stress
in clinical severity of chronic heart disease in Chagasic
patients.
Abbreviations
CI: NADH ubiquinone oxidoreductase
CII: Succinate decylubiquinone 2, 6
dichlorophenolindophenolreductase
CIII: Ubiquinol cytochrome c
oxidoreductase
CIV: Cytochrome c oxidase
cyt c: Cytochrome c
GSH: Glutathione
GPx: Glutathione peroxidase
HNE: 4-hydroxynonenal
MDA: Malonyldialdehyde
MPO: Myeloperoxidase
NADH: Nicotinamide adenine dinucleotide
(reduced form)
NOS: Nitric oxide synthase
PBN: Phenyl-N-tert-butylnitrone
ROS: Reactive oxygen species
SOD: Superoxide dismutase
T. cruzi: Trypanosoma cruzi.
Acknowledgments
The work discussed in this review was supported by
Grants from the National Heart, Lung, and Blood Institute
(HL088320 and HL094802) and the National Institutes of
Allergy and Infectious Diseases (AI053098 and AI054578)
of the National Institutes of Health, John Sealy Memo-
rial Endowment Fund for Biomedical Research, and the
American Health Assistance Foundation. The authors also
would like to thank Ms. Mardelle Susman for editing the
manuscript.
References
[1] World Health Organization, “Report of the scientiﬁc work-
ing group on chagas disease,” Tech. Rep., UNDP/World
Bank/WHO, Buenos Aires, Argentina, 2006.
[2] Z.Brener,“Presentstatusofchemotherapyandchemoprophy-
laxis of human trypanosomiasis in the Western Hemisphere,”
Pharmacology & Therapeutics, vol. 7, no. 1, pp. 71–90, 1979.
[3] J.MileiandR.Storino,“Earlymyocardialinfarction.Afeasible
histologic diagnostic procedure,” Japanese Heart Journal, vol.
27, no. 3, pp. 307–319, 1986.
[4] C. A. Santos-Buch and A. M. Acosta, “Pathology of Chagas’
disease,” in Immunology and Pathology of Trypanosomiasis,I .
Tizard, Ed., pp. 145–183, CRC Press, Boca Raton, Fla, USA,
1985.
[5] Z. A. Andrade, S. G. Andrade, R. Correa, M. Sadigursky, and
V. J. Ferrans, “Myocardial changes in acute Trypanosoma cruzi
infection.Ultrastructuralevidenceofimmunedamageandthe
role of microangiopathy,” The American Journal of Pathology,
vol. 144, no. 6, pp. 1403–1411, 1994.
[6] A. Rassi Jr., A. Rassi, and W. C. Little, “Chagas’ heart disease,”
Clinical Cardiology, vol. 23, no. 12, pp. 883–889, 2000.
[7] M. de Lourdes Higuchi, L. A. Benvenuti, M. M. Reis,
and M. Metzger, “Pathophysiology of the heart in Chagas’
disease: current status and new developments,” Cardiovascular
Research, vol. 60, no. 1, pp. 96–107, 2003.
[8] M. B. P. Scares, L. Pontes-De-Carvalho, and R. Ribeiro-
Dos-Santos, “The pathogenesis of Chagas’ disease: when
autoimmune and parasite-speciﬁc immune responses meet,”
Anais da Academia Brasileira de Ciˆ encias, vol. 73, no. 4, pp.
547–559, 2001.
[9] F. Kierszenbaum, “Mechanisms of pathogenesis in Chagas
disease,” Acta Parasitologica, vol. 52, no. 1, pp. 1–12, 2007.
[10] J. F. Turrens, “Mitochondrial formation of reactive oxygen
species,”TheJournalofPhysiology,vol.552,no.2,pp.335–344,
2003.
[11] P.J.AndrewandB.Mayer, “Enzymaticfunctionofnitricoxide
synthases,” Cardiovascular Research, vol. 43, no. 3, pp. 521–
531, 1999.
[12] M. N. Alvarez, L. Piacenza, F. Irigo´ ın, G. Peluﬀo, and R. Radi,
“Macrophage-derived peroxynitrite diﬀusion and toxicity to
Trypanosoma cruzi,” Archives of Biochemistry and Biophysics,
vol. 432, no. 2, pp. 222–232, 2004.
[13] M. A. Mu˜ noz-Fern´ andez, M. A. Fern´ andez, and M. Fresno,
“Activation of human macrophages for the killing of intra-
cellular Trypanosoma cruzi by TNF-α and IFN-γ through a
nitric oxide-dependent mechanism,” Immunology Letters, vol.
33, no. 1, pp. 35–40, 1992.
[ 1 4 ]R .C .M e l o ,D .L .F a b r i n o ,H .D ’ A v i l a ,H .C .T e i x e i r a ,
and A. P. Ferreira, “Production of hydrogen peroxide by
peripheral blood monocytes and speciﬁc macrophages during
experimental infection with Trypanosoma cruzi in vivo,” Cell
Biology International, vol. 27, no. 10, pp. 853–861, 2003.
[15] G.A.Martins,M.A.G.Cardoso ,J .C.S.Aliberti,andJ .S.Silva,
“Nitric oxide-induced apoptotic cell death in the acute phase6 Interdisciplinary Perspectives on Infectious Diseases
of Trypanosoma cruzi infection in mice,” Immunology Letters,
vol. 63, no. 2, pp. 113–120, 1998.
[16] M. Bergeron and M. Olivier, “Trypanosoma cruzi-mediated
IFN-γ-inducible nitric oxide output in macrophages is regu-
lated by iNOS mRNA stability,” The Journal of Immunology,
vol. 177, no. 9, pp. 6271–6280, 2006.
[17] M. Dhiman, J. G. Estrada-Franco, J. M. Pando, et al.,
“Increased myeloperoxidase activity and protein nitration are
indicators of inﬂammation in patients with Chagas’ disease,”
Clinical and Vaccine Immunology, vol. 16, no. 5, pp. 660–666,
2009.
[18] R. P´ erez-Fuentes, J.-F. Gu´ egan, C. Barnab´ e, et al., “Severity of
chronicChagasdiseaseisassociatedwithcytokine/antioxidant
imbalance in chronically individuals,” InternationalJournalfor
Parasitology, vol. 33, no. 3, pp. 293–299, 2003.
[19] R. P´ erez-Fuentes, M. D. C. S´ anchez-Guill´ en, C. Gonz´ alez-
Alvarez, V. M. Monte´ on, P. A. Reyes, and J. L. Rosales-Encina,
“Humoral nitric oxide levels and antibody immune response
of symptomatic and indeterminate Chagas’ disease patients to
commercial and autochthonous Trypanosoma cruzi antigen,”
The American Journal of Tropical Medicine and Hygiene, vol.
58, no. 6, pp. 715–720, 1998.
[20] H.A.CarrascoGuerra,E.Palacios-Pr¨ u,C.DagertdeScorza,C.
Molina, G. Inglessis, and R. V. Mendoza, “Clinical, histochem-
ical, and ultrastructural correlation in septal endomyocardial
biopsies from chronic chagasic patients: detection of early
myocardial damage,” American Heart Journal, vol. 113, no. 3,
pp. 716–724, 1987.
[21] E. Palacios-Pru, H. Carrasco, C. Scorza, and R. Espinoza,
“Ultrastructural characteristics of diﬀerent stages of human
chagasic myocarditis,” The American Journal of Tropical
Medicine and Hygiene, vol. 41, no. 1, pp. 29–40, 1989.
[ 2 2 ]H .P a r a d a ,H .AC a r r a s c o ,N .A ˜ nez, C. Fuenmayor, and I.
Inglessis, “Cardiac involvement is a constant ﬁnding in acute
Chagas’ disease: a clinical, parasitological and histopatholog-
ical study,” International Journal of Cardiology, vol. 60, no. 1,
pp. 49–54, 1997.
[23] N. Garg, V. L. Popov, and J. Papaconstantinou, “Proﬁling
genetranscriptionrevealsadeﬁciencyofmitochondrialoxida-
tive phosphorylation in Trypanosoma cruzi-infected murine
hearts: implications in chagasic myocarditis development,”
Biochimica et Biophysica Acta, vol. 1638, no. 2, pp. 106–120,
2003.
[24] E. Cunha-Neto, V. J. Dzau, P. D. Allen, et al., “Cardiac gene
expression proﬁling provides evidence for cytokinopathy as
a molecular mechanism in Chagas’ disease cardiomyopathy,”
American Journal of Pathology, vol. 167, no. 2, pp. 305–313,
2005.
[25] S. Mukherjee, T. J. Belbin, D. C. Spray, et al., “Microarray
analysis of changes in gene expression in a murine model of
chronic chagasic cardiomyopathy,” Parasitology Research, vol.
91, no. 3, pp. 187–196, 2003.
[26] N. Garg, A. Gerstner, V. Bhatia, J. DeFord, and J. Papacon-
stantinou, “Gene expression analysis in mitochondria from
chagasic mice: alterations in speciﬁc metabolic pathways,”
Biochemical Journal, vol. 381, no. 3, pp. 743–752, 2004.
[27] G. Vyatkina, V. Bhatia, A. Gerstner, J. Papaconstantinou,
and N. Garg, “Impaired mitochondrial respiratory chain and
bioenergetics during chagasic cardiomyopathy development,”
Biochimica et Biophysica Acta, vol. 1689, no. 2, pp. 162–173,
2004.
[28] S. A. Uyemura, M. C. Jordani, A. C. M. Polizello, and C.
Curti, “Heart FoF1-ATPase changes during the acute phase of
Trypanosoma cruzi infection in rats,” Molecular and Cellular
Biochemistry, vol. 165, no. 2, pp. 127–133, 1996.
[29] S. A. Uyemura, S. Albuquerque, and C. Curti, “Energetics of
heart mitochondria during acute phase of Trypanosoma cruzi
infection in rats,” The International Journal of Biochemistry &
Cell Biology, vol. 27, no. 11, pp. 1183–1189, 1995.
[30] J.-J. Wen, V. Bhatia, V. L. Popov, and N. J. Garg, “Phenyl-
α-tert-butyl nitrone reverses mitochondrial decay in acute
Chagas’ disease,” American Journal of Pathology, vol. 169, no.
6, pp. 1953–1964, 2006.
[31] A. Boveris, N. Oshino, and B. Chance, “The cellular produc-
tion of hydrogen peroxide,” Biochemical Journal, vol. 128, no.
3, pp. 617–630, 1972.
[32] T. Ide, H. Tsutsui, S. Kinugawa, et al., “Mitochondrial electron
transport complex I is a potential source of oxygen free
radicals in the failing myocardium,” Circulation Research, vol.
85, no. 4, pp. 357–363, 1999.
[33] Q. Chen, E. J. Vazquez, S. Moghaddas, C. L. Hoppel, and
E. J. Lesnefsky, “Production of reactive oxygen species by
mitochondria: central role of complex III,” The Journal of
Biological Chemistry, vol. 278, no. 38, pp. 36027–36031, 2003.
[34] J. J. Wen and N. J. Garg, “Mitochondrial generation of reactive
oxygen species is enhanced at the Qo site of the complex
III in the myocardium of Trypanosoma cruzi-infected mice:
beneﬁcial eﬀects of an antioxidant,” Journal of Bioenergetics
and Biomembranes, vol. 40, no. 6, pp. 587–598, 2008.
[35] I. Fridovich, “Superoxide radical and superoxide dismutases,”
Annual Review of Biochemistry, vol. 64, pp. 97–112, 1995.
[36] I. Fridovich, “Superoxide dismutases,” in Advances in Enzy-
mology and Related Areas of Molecular Biology, Vol. 41, pp. 35–
97, John Wiley & Sons, New York, NY, USA, 1974.
[ 3 7 ]J .N o r d b e r ga n dE .S .J .A r n ´ er, “Reactive oxygen species,
antioxidants, and the mammalian thioredoxin system,” Free
Radical Biology and Medicine, vol. 31, no. 11, pp. 1287–1312,
2001.
[38] H. Z. Chae, S. W. Kang, and S. G. Rhee, “Isoforms of
mammalian peroxiredoxin that reduce peroxides in presence
ofthioredoxin,”Methods in Enzymology,vol.300,pp.219–226,
1999.
[39] N. S. Dhalla, A. B. Elmoselhi, T. Hata, and N. Makino, “Status
of myocardial antioxidants in ischemia-reperfusion injury,”
Cardiovascular Research, vol. 47, no. 3, pp. 446–456, 2000.
[40] N. Marczin, N. El-Habashi, G. S. Hoare, R. E. Bundy, and
M. Yacoub, “Antioxidants in myocardial ischemia-reperfusion
injury: therapeutic potential and basic mechanisms,” Archives
of Biochemistry and Biophysics, vol. 420, no. 2, pp. 222–236,
2003.
[41] J.-J. Wen and N. Garg, “Oxidative modiﬁcation of mito-
chondrial respiratory complexes in response to the stress
of Trypanosoma cruzi infection,” Free Radical Biology and
Medicine, vol. 37, no. 12, pp. 2072–2081, 2004.
[42] J.-J. Wen, P. C. Yachelini, A. Sembaj, R. E. Manzur, and
N. J. Garg, “Increased oxidative stress is correlated with
mitochondrial dysfunction in chagasic patients,” Free Radical
Biology and Medicine, vol. 41, no. 2, pp. 270–276, 2006.
[43] T. B. de Oliveira, R. C. Pedrosa, and D. W. Filho, “Oxidative
stress in chronic cardiopathy associated with Chagas disease,”
International Journal of Cardiology, vol. 116, no. 3, pp. 357–
363, 2007.
[44] T. Finkel, “Oxidant signals and oxidative stress,” Currnet
Opinion in Cell Biology, vol. 15, no. 2, pp. 247–254, 2003.
[45] W. Dr¨ oge, “Free radicals in the physiological control of cell
function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95,
2002.Interdisciplinary Perspectives on Infectious Diseases 7
[46] A. Valenzuela, “The biological signiﬁcance of malondialde-
hyde determination in the assessment of tissue oxidative
stress,” Life Sciences, vol. 48, no. 4, pp. 301–309, 1991.
[47] H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides
in animal tissues by thiobarbituric acid reaction,” Analytical
Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.
[48] N. Zarkovic, “4-hydroxynonenal as a bioactive marker of
pathophysiological processes,” Molecular Aspects of Medicine,
vol. 24, no. 4-5, pp. 281–291, 2003.
[49] K. Uchida and E. R. Stadtman, “Modiﬁcation of histidine
residues in proteins by reaction with 4-hydroxynonenal,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 89, no. 10, pp. 4544–4548, 1992.
[50] D. A. Butterﬁeld, T. Koppal, B. Howard, et al., “Structural
and functional changes in proteins induced by free radical-
mediated oxidative stress and protective action of the antioxi-
dants N-tert-butyl-α-phenylnitrone and vitamin E,” Annals of
the New York Academy of Sciences, vol. 854, pp. 448–462, 1998.
[51] M. Chevion, E. Berenshtein, and E. R. Stadtman, “Human
studies related to protein oxidation: protein carbonyl content
as a marker of damage,” Free Radical Research, vol. 33,
supplement, pp. S99–S108, 2000.
[52] F. J. Schopfer, P. R. S. Baker, and B. A. Freeman, “NO-
dependent protein nitration: a cell signaling event or an
oxidative inﬂammatory response?” Trends in Biochemical
Sciences, vol. 28, no. 12, pp. 646–654, 2003.
[ 5 3 ]R .A .F l o y d ,M .W e s t ,a n dK .H e n s l e y ,“ O x i d a t i v eb i o c h e m i c a l
markers; clues to understanding aging in long-lived species,”
Experimental Gerontology, vol. 36, no. 4–6, pp. 619–640, 2001.
[54] M. D. Evans and M. S. Cooke, “Factors contributing to the
outcome of oxidative damage to nucleic acids,” BioEssays, vol.
26, no. 5, pp. 533–542, 2004.
[55] A. B. Youn´ es-Chennouﬁ, M. Hontebeyrie-Joskowicz, V. Tri-
cottet, H. Eisen, M. Reynes, and G. Said, “Persistence of
Trypanosoma cruzi antigens in the inﬂammatory lesions of
chronically infected mice,” Transactions of the Royal Society of
Tropical Medicine and Hygiene, vol. 82, no. 1, pp. 77–83, 1988.
[56] R. L. Cardoni, M. I. Antunez, C. Morales, and I. Rodriguez
Nantes, “Release of reactive oxygen species by phagocytic cells
inresponsetoliveparasitesinmiceinfectedwithTrypanosoma
cruzi,” The American Journal of Tropical Medicine and Hygiene,
vol. 56, no. 3, pp. 329–334, 1997.
[57] F. Villalta and F. Kierszenbaum, “Role of polymorphonuclear
cells in Chagas’ disease. I. Uptake and mechanisms of destruc-
tion of intracellular (amastigote) forms of Trypanosoma cruzi
by human neutrophils,” The Journal of Immunology, vol. 131,
no. 3, pp. 1504–1510, 1983.
[58] J.-J. Wen, M. Dhiman, E. B. Whorton, and N. J. Garg, “Tissue-
speciﬁc oxidative imbalance and mitochondrial dysfunction
during Trypanosoma cruzi infection in mice,” Microbes and
Infection, vol. 10, no. 10-11, pp. 1201–1209, 2008.
[59] B. Chance, H. Sies, and A. Boveris, “Hydroperoxide
metabolism in mammalian organs,” Physiological Reviews, vol.
59, no. 3, pp. 527–605, 1979.
[60] A. Boveris, E. Cadenas, and A. O. M. Stoppani, “Role of
ubiquinone in the mitochondrial generation of hydrogen
peroxide,” Biochemical Journal, vol. 156, no. 2, pp. 435–444,
1976.
[61] J. F. Turrens, “The potential of antioxidant enzymes as
pharmacologicalagentsinvivo,”Xenobiotica,v ol.21,no .8,pp .
1033–1040, 1991.
[62] K. Carvajal and R. Moreno-S´ anchez, “Heart metabolic dis-
turbances in cardiovascular diseases,” Archives of Medical
Research, vol. 34, no. 2, pp. 89–99, 2003.
[63] D. Han, R. Canali, D. Rettori, and N. Kaplowitz, “Eﬀect of
gutathione depletion on sites and topology of superoxide and
hydrogen peroxide production in mitochondria,” Molecular
Pharmacology, vol. 64, no. 5, pp. 1136–1144, 2003.
[64] B. Halliwell and J. M. C. Gutteridge, “Oxygen toxicity, oxygen
radicals, transition metals and disease,” Biochemical Journal,
vol. 219, no. 1, pp. 1–14, 1984.
[65] L. Y. Brovko, N. A. Romanova, and N. N. Ugarova, “Bio-
luminescent assay of bacterial intracellular AMP, ADP, and
ATP with the use of a coimmobilized three-enzyme reagent
(adenylate kinase, pyruvate kinase, and ﬁreﬂy luciferase),”
Analytical Biochemistry, vol. 220, no. 2, pp. 410–414, 1994.
[66] J. D. Rush and W. H. Koppenol, “Oxidizing intermediates
in the reaction of ferrous EDTA with hydrogen peroxide.
Reactions with organic molecules and ferrocytochrome C,”
The Journal of Biological Chemistry, vol. 261, no. 15, pp. 6730–
6733, 1986.
[67] D. A. Dickinson and H. J. Forman, “Glutathione in defense
and signaling: lessons from a small thiol,” Annals of the New
York Academy of Sciences, vol. 973, pp. 488–504, 2002.
[68] J. Wang, H. Chen, T. Wang, Y. Diao, and K. Tian, “Oxygen-
derivedfreeradicalsinducedcellularinjuryinsuperiormesen-
teric artery occlusion shock: protective eﬀect of superoxide
dismutase,” Circulatory Shock, vol. 32, no. 1, pp. 31–41, 1990.
[69] S. Cuzzocrea, G. Costantino, E. Mazzon, A. De Sarro, and A. P.
Caputi, “Beneﬁcial eﬀects of Mn(III)tetrakis (4-benzoic acid)
porphyrin (MnTBAP), a superoxide dismutase mimetic, in
zymosan-inducedshock,”BritishJournalofPharmacology,vol.
128, no. 6, pp. 1241–1251, 1999.
[70] D. Salvemini, Z.-Q. Wang, J. L. Zweier, et al., “A nonpeptidyl
mimic of superoxide dismutase with therapeutic activity in
rats,” Science, vol. 286, no. 5438, pp. 304–306, 1999.
[ 7 1 ] R .A .F l o y d ,K .H e n s l e y ,M .J .F o r s t e r ,J .A .K e l l e h e r - A n d e r s o n ,
and P. L. Wood, “Nitrones as neuroprotectants and antiaging
drugs,” Annals of the New York Academy of Sciences, vol. 959,
pp. 321–329, 2002.
[72] Y. Kotake, “Pharmacologic properties of phenyl N-tert-
butylnitrone,” Antioxidants & Redox Signaling, vol. 1, no. 4,
pp. 481–499, 1999.
[73] L. B. Mac ¸ao, D. W. Filho, R. C. Pedrosa, et al., “Antioxidant
therapy attenuates oxidative stress in chronic cardiopathy
associated with Chagas’ disease,” International Journal of
Cardiology, vol. 123, no. 1, pp. 43–49, 2007.
[74] J. S. M. Oliveira, “A natural human model of intrinsic heart
nervous system denervation: Chagas’ cardiopathy,” American
Heart Journal, vol. 110, no. 5, pp. 1092–1098, 1985.
[75] J. A. Marin-Neto, M. V. Sim˜ oes, E. M. Ayres-Neto, et al.,
“Studies of the coronary circulation in Chagas’ heart disease,”
S˜ ao Paulo Medical Journal, vol. 113, no. 2, pp. 826–834, 1995.
[76] H. Acquatella and N. B. Schiller, “Echocardiographic recogni-
tion of Chagas’ disease and endomyocardial ﬁbrosis,” Journal
of the American Society of Echocardiography, vol. 1, no. 1, pp.
60–68, 1988.
[77] M. A. Rossi, “Microvascular changes as a cause of chronic
cardiomyopathy in Chagas’ disease,” American Heart Journal,
vol. 120, no. 1, pp. 233–236, 1990.
[78] M. A. Rossi, “Aortic endothelial cell changes in the acute sep-
ticemic phase of experimental Trypanosoma cruzi infection in
rats: scanning and transmission electron microscopic study,”
The American Journal of Tropical Medicine and Hygiene, vol.
57, no. 3, pp. 321–327, 1997.
[79] H. B. Tanowitz, D. K. Kaul, B. Chen, et al., “Compromised
microcirculation in acute murine Trypanosoma cruzi infec-
tion,” Journal of Parasitology, vol. 82, no. 1, pp. 124–130, 1996.8 Interdisciplinary Perspectives on Infectious Diseases
[80] S. G. Ramos and M. A. Rossi, “Microcirculation and Chagas’
disease: hypothesis and recent results,” Revista do Instituto de
Medicina Tropical de Sao Paulo, vol. 41, no. 2, pp. 123–129,
1999.
[81] H. M. Piper, T. Noll, and B. Siegmund, “Mitochondrial
function in the oxygen depleted and reoxygenated myocardial
cell,” Cardiovascular Research, vol. 28, no. 1, pp. 1–15, 1994.
[82] V. Borutaite, R. Morkuniene, A. Budriunaite, et al., “Kinetic
analysisofchangesinactivityofheartmitochondrialoxidative
phosphorylation system induced by ischemia,” Journal of
Molecular and Cellular Cardiology, vol. 28, no. 10, pp. 2195–
2201, 1996.
[83] R. B. Jennings and C. E. Ganote, “Mitochondrial structure
and function in acute myocardial ischemic injury,” Circulation
Research, vol. 38, no. 5, supplement 1, pp. 80–91, 1976.
[84] K. Ataka, D. Chen, S. Levitsky, E. Jimenez, and H. Feinberg,
“Eﬀect of aging on intracellular Ca
2+, pHi, and contractility
during ischemia and reperfusion,” Circulation,v o l .8 6 ,n o .5 ,
supplement 2, pp. 371–376, 1992.
[85] V. Borutaite and G. C. Brown, “Mitochondria in apoptosis of
ischemic heart,” FEBS Letters, vol. 541, no. 3, pp. 1–5, 2003.
[86] M. Shlafer, C. L. Myers, and S. Adkins, “Mitochondrial hydro-
gen peroxide generation and activities of glutathione perox-
idase and superoxide dismutase following global ischemia,”
Journal of Molecular and Cellular Cardiology, vol. 19, no. 12,
pp. 1195–1206, 1987.
[87] E. J. Lesnefsky, S. Moghaddas, B. Tandler, J. Kerner, and C.
L. Hoppel, “Mitochondrial dysfunction in cardiac disease:
ischemia-reperfusion, aging, and heart failure,” Journal of
Molecular and Cellular Cardiology, vol. 33, no. 6, pp. 1065–
1089, 2001.
[ 8 8 ]R .A .S i m o n y a na n dV .P .S k u l a c h e v ,“ T h e r m o r e g u l a t o r y
uncoupling in heart muscle mitochondria: involvement of the
ATP/ADP antiporter and uncoupling protein,” FEBS Letters,
vol. 436, no. 1, pp. 81–84, 1998.
[89] S. S. Korshunov, B. F. Krasnikov, M. O. Pereverzev, and V. P.
Skulachev,“Theantioxidantfunctionsofcytochromec,” FEBS
Letters, vol. 462, no. 1, pp. 192–198, 1999.